NASDAQ: OBIO - Orchestra BioMed Holdings, Inc.

Rentabilität für sechs Monate: -17.07%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Orchestra BioMed Holdings, Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions.

weitere details
The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2020-08-04
ISIN US68572M1062
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://orchestrabiomed.com
Цена ао 3.84
Preisänderung pro Tag: +6.25% (3.84)
Preisänderung pro Woche: -3.55% (4.23)
Preisänderung pro Monat: -23.45% (5.33)
Preisänderung über 3 Monate: -22.43% (5.26)
Preisänderung über sechs Monate: -17.07% (4.92)
Preisänderung pro Jahr: -23.31% (5.32)
Preisänderung über 3 Jahre: -58.75% (9.89)
Preisänderung seit Jahresbeginn: -17.07% (4.92)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 119.06 1
P/BV 4.83 3
P/E 0 0
EV/EBITDA -5.85 0
Gesamt: 2.88

Effizienz

Name Bedeutung Grad
ROA, % -51.59 0
ROE, % -72.19 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.0329 10
Gesamt: 9.8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -51.58 0
Rentabilität Ebitda, % 175.37 10
Rentabilität EPS, % 118.86 10
Gesamt: 7.6
Weitere Details

Institutionen Volumen Aktie, %
RTW Investments LP 5620640 15.71
Perceptive Advisors LLC 2432089 6.8
Blackrock Inc. 1468768 4.11
Vanguard Group Inc 1227282 3.43
Price (T.Rowe) Associates Inc 622608 1.74
Geode Capital Management, LLC 425749 1.19
State Street Corporation 285910 0.8
Boxer Capital, LLC 238193 0.67
Charles Schwab Investment Management, Inc. 175545 0.49
Northern Trust Corporation 142879 0.4

ETFAktie, %Rentabilität für das Jahr, %Dividenden, %
iShares Micro-Cap ETF 0.02967 17.09 1.54048
Vanguard Russell 2000 ETF 0.01 17.16 1.48801
iShares Russell 2000 Growth ETF 0.00387 38.04 0.6026
Schwab U.S. Small-Cap ETF 0.00339 17.47 1.51433
ProShares UltraPro Russell2000 0.00248 89.82 1.47873
Avantis U.S Small Cap Equity ETF 0.00162 27.77 1.68271
ProShares Hedge Replication ETF 0.00069 5.92 1.47892
Schwab U.S. Broad Market ETF 0.00032 24.86 1.43354
Vanguard Russell 2000 Growth ETF 0 23.05 0.60264
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.0000029.31.32



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. David P. Hochman Founder, Chairman of the Board of Directors & CEO 942k 1975 (50 Jahre)
Mr. Darren R. Sherman Founder, President, COO & Director 787k 1971 (54 Jahr)
Mr. Andrew Lawrence Taylor M.B.A. Chief Financial Officer 500.02k 1971 (54 Jahr)
Mr. William Reed Little Executive Vice President of Corporate Development & Strategy N/A 1971 (54 Jahr)
Dr. Yuval Hay Mika D.Sc, Ph.D. GM & CTO of Bioelectronic Therapies N/A 1959 (66 Jahre)
Dr. George Papandreou Ph.D. GM & Senior VP of Focal Therapies N/A 1965 (60 Jahre)
Dr. Hans-Peter Stoll M.D., Ph.D. Chief Clinical Officer N/A
Dr. Avraham Matityahu Fischer M.D. Senior Vice President of Medical Affairs & Innovation N/A 1956 (69 Jahre)
Mr. Bob Laughner Senior Vice President of Regulatory & Quality N/A
Mr. Juan Lorenzo Senior Vice President of Product Development N/A

Adresse: United States, New Hope. PA, 150 Union Square Drive - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://orchestrabiomed.com